Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ke Su

Showing results (231-240 of 236) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 236 results.
Frontiers in Immunology|October 10, 2022
PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching studyKe Su, Lu Guo, Wenqiong Ma, et al.
Frontiers in Oncology|August 19, 2022
PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinomaKe Su, Lu Guo, Kun He, et al.
International Journal of Radiation Oncology, Biology, Physics|September 19, 2025
Survival Benefit of Adjuvant Radiation Therapy Following Asparaginase-Based Chemotherapy in Patients With Chemoresponsive Advanced-Stage Extranodal NK/T Cell Lymphoma: A Multicenter Study Using the China Lymphoma Collaborative Group DatabaseKe Su, Xiao-Rong Hou, Qiu-Zi Zhong, et al.
Hepatology International|June 21, 2022
Gamma knife radiosurgery versus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score matching studyKe Su, Tao Gu, Ke Xu, et al.
Hepatology International|August 16, 2022
Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter studyKe Su, Yanlin Liu, Pan Wang, et al.
HGG Advances|June 26, 2026
Expanding the ABCA2-associated neurodevelopmental phenotypeKaisa T Oja, Karit Reinson, Mihkel Ilisson, et al.
Pageof 24

Showing results (231-240 of 236) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 236 results.
Frontiers in Immunology|October 10, 2022
PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching studyKe Su, Lu Guo, Wenqiong Ma, et al.
Frontiers in Oncology|August 19, 2022
PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinomaKe Su, Lu Guo, Kun He, et al.
International Journal of Radiation Oncology, Biology, Physics|September 19, 2025
Survival Benefit of Adjuvant Radiation Therapy Following Asparaginase-Based Chemotherapy in Patients With Chemoresponsive Advanced-Stage Extranodal NK/T Cell Lymphoma: A Multicenter Study Using the China Lymphoma Collaborative Group DatabaseKe Su, Xiao-Rong Hou, Qiu-Zi Zhong, et al.
Hepatology International|June 21, 2022
Gamma knife radiosurgery versus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score matching studyKe Su, Tao Gu, Ke Xu, et al.
Hepatology International|August 16, 2022
Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter studyKe Su, Yanlin Liu, Pan Wang, et al.
HGG Advances|June 26, 2026
Expanding the ABCA2-associated neurodevelopmental phenotypeKaisa T Oja, Karit Reinson, Mihkel Ilisson, et al.
Pageof 24